| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 4 449-456, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
RA Ross, BA Spengler, C Domenech, M Porubcin, WJ Rettig and JL Biedler
Department of Biological Sciences, Fordham University, Bronx, New York 10458, USA.
Human neuroblastoma I-type cells isolated from cell lines in vitro are morphologically intermediate between neuroblastic (N) cells, with properties of embryonic sympathoblasts, and substrate-adherent (S) cells having properties of embryonic Schwann/glial/melanocytic cells of the neural crest. I cells have biochemical features of both N and S cells. We propose that the I-type cell represents a malignant neural crest stem cell. The strongest evidence in support of this hypothesis is that: (a) I cells can generate progeny that have neuronal properties, i.e., are committed neuroblasts, or properties of nonneuronal, embryonic neural crest-derived cells; and (b) I-type cells can generate multipotent I-type progeny, indicating their capacity for self-renewal, a feature of stem cells. We report here that I-type cells, derived from four different human neuroblastoma cell lines and experimentally induced to differentiate, give rise to cells with distinct N or S cell phenotypes, indicative of I cell multipotentiality. Experiments with a large panel of I-type subclones, isolated from clonal I-type BE(2)-C cells and exposed to retinoic acid to induce neuronal differentiation or 5-bromo-2'-deoxyuridine to obtain S-type cells, demonstrated that differentiation occurs via induction and selection and not by selection of spontaneously arising variants. The differentiation phenotype was stable. We conclude that human neuroblastoma I-type cells are multipotent embryonic precursor cells of the peripheral nervous system, capable of either neuronal or nonneuronal neural crest cell differentiation.
This article has been cited by other articles:
![]() |
H. Cui, J. Ma, J. Ding, T. Li, G. Alam, and H.-F. Ding Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner J. Biol. Chem., November 10, 2006; 281(45): 34696 - 34704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Monroe and S. W. Halvorsen Mercury Abolishes Neurotrophic Factor-Stimulated Jak-STAT Signaling in Nerve Cells by Oxidative Stress Toxicol. Sci., November 1, 2006; 94(1): 129 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nowak, K. Kerl, D. Fehr, C. Kramps, C. Gessner, K. Killmer, B. Samans, B. Berwanger, H. Christiansen, and W. Lutz BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res., January 1, 2006; 34(6): 1745 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Baumann Kubetzko, C. di Paolo, C. Maag, R. Meier, B. W. Schafer, D. R. Betts, R. A. Stahel, and A. Himmelmann The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line Carcinogenesis, October 1, 2004; 25(10): 1839 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alaminos, V. Davalos, N.-K. V. Cheung, W. L. Gerald, and M. Esteller Clustering of Gene Hypermethylation Associated With Clinical Risk Groups in Neuroblastoma J Natl Cancer Inst, August 18, 2004; 96(16): 1208 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Yu, A. Nakajima, H. Nakajima, L. R. Diller, K. D. Bloch, and D. B. Bloch Restoration of Promyelocytic Leukemia Protein-Nuclear Bodies in Neuroblastoma Cells Enhances Retinoic Acid Responsiveness Cancer Res., February 1, 2004; 64(3): 928 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, D. Li, M. K. Pasumarthy, T. H. Kowalczyk, C. R. Gedeon, S. L. Hyatt, J. M. Payne, T. J. Miller, P. Brunovskis, T. L. Fink, et al. Nanoparticles of Compacted DNA Transfect Postmitotic Cells J. Biol. Chem., August 29, 2003; 278(35): 32578 - 32586. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bian, A. W. Opipari Jr., A. B. Ratanaproeksa, A. E. Boitano, P. C. Lucas, and V. P. Castle Constitutively Active NFkappa B Is Required for the Survival of S-type Neuroblastoma J. Biol. Chem., October 25, 2002; 277(44): 42144 - 42150. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mora, N.-K. V. Cheung, G. Juan, P. Illei, I. Cheung, M. Akram, S. Chi, M. Ladanyi, C. Cordon-Cardo, and W. L. Gerald Neuroblastic and Schwannian Stromal Cells of Neuroblastoma Are Derived from a Tumoral Progenitor Cell Cancer Res., September 1, 2001; 61(18): 6892 - 6898. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Wainwright, A. Lasorella, and A. Iavarone Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells PNAS, July 31, 2001; 98(16): 9396 - 9400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |